Can You Take Creatine With NMN or NR? A Women's Guide to Stacking These Supplements Safely

The Short Answer on Taking Both Together

No published study has found a direct pharmacokinetic or pharmacodynamic interaction between creatine monohydrate and either nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR). They work through separate biochemical pathways, they are absorbed by different transporters, and they do not compete for the same enzymes in any well-documented way. You can take them in the same supplement stack without one blocking the other.

The combination does create one clinically important complication: creatine supplementation raises serum creatinine, a standard kidney function marker, by an average of 0.1-0.2 mg/dL in healthy adults. For a woman with a small muscle mass, even that modest rise can push her creatinine reading close to or just above the lab's upper reference range, triggering unnecessary concern or, worse, an incorrect dose reduction of another medication that is renally cleared.

This guide untangles the mechanisms, sets realistic expectations for each life stage, and gives you a practical monitoring checklist.

How NMN and NR Work in the Female Body

The NAD+ Connection

NMN and NR are both precursors to nicotinamide adenine dinucleotide (NAD+), a coenzyme your cells need for energy production, DNA repair, and the activity of sirtuins, a family of proteins linked to cellular aging. NAD+ levels decline with age in both sexes, but the trajectory in women appears to track hormonal shifts. Estrogen influences the kynurenine pathway, which is one of the body's own NAD+ synthesis routes, so the perimenopausal estrogen drop may accelerate NAD+ decline at a time when women are already dealing with fatigue, cognitive fog, and muscle changes.

NMN is converted to NMN-nucleotide inside cells and then to NAD+. NR takes a slightly shorter route via nicotinamide riboside kinase. Both end up in the same pool.

Human Trial Data for Women

A 2023 randomized controlled trial published in Nature Aging found that 12 weeks of 900 mg per day NMN raised blood NAD+ metabolite levels in adults aged 40-65, with a mean age close to the perimenopausal window. The trial enrolled both sexes, but the authors did not report sex-stratified efficacy data, which is a real evidence gap. A smaller 2021 placebo-controlled trial in postmenopausal women using NMN at 250 mg per day for 10 weeks showed improved muscle insulin sensitivity and enhanced skeletal muscle gene expression related to glucose uptake. That trial enrolled only women (average age 65), making it one of the few female-specific NAD+ precursor datasets available.

NR has a comparable evidence base. A 2018 clinical pharmacology study in Cell Metabolism confirmed that NR at 1,000 mg per day raised whole-blood NAD+ by roughly 2.7-fold in healthy middle-aged adults, again without sex-stratified results.

A working framework for women by life stage:

| Life Stage | Relevant NAD+ Physiology | Practical Consideration | |---|---|---| | Reproductive years | Estrogen supports kynurenine-to-NAD+ synthesis | Less clear benefit; most trial data is in older adults | | Perimenopause (45-52) | Estrogen declining; NAD+ decline may accelerate | Most biologically plausible window for supplementation | | Postmenopause | Lower estrogen, reduced biosynthesis capacity | Best-evidenced group; insulin sensitivity and muscle data apply here | | Pregnancy / lactation | Safety data absent | Avoid both NMN and NR (see dedicated section below) |

How Creatine Works and Why It Matters for Women

Creatine's Mechanism

Creatine is stored in muscle as phosphocreatine and serves as a rapid phosphate donor during high-intensity effort. Supplementation saturates muscle stores, which typically takes 5-7 days at a loading dose of 20 g per day or 3-4 weeks at a maintenance dose of 3-5 g per day. Once muscle is saturated, excess creatine is spontaneously converted to creatinine and excreted by the kidneys.

That last step is the source of the lab concern. Creatinine is also the standard marker used to calculate estimated glomerular filtration rate (eGFR), the primary kidney function test your doctor orders. Higher creatinine from creatine supplementation can lower your calculated eGFR and make your kidneys appear to be working less well than they actually are.

Women-Specific Creatine Physiology

Women have approximately 70-80% lower total muscle creatine stores than men of similar body weight, partly because creatine is synthesized in muscle and women carry less muscle mass on average. This means:

• Women may respond to lower doses (3 g per day is often sufficient for muscle saturation).
• The creatinine elevation from supplementation may be proportionally more noticeable on standard lab panels because women's baseline creatinine is already lower.
• The clinical benefit per gram of creatine may be higher in women who are creatine-deficient relative to men.

A 2021 review in Nutrients examining creatine specifically in women found that women in the postmenopausal period showed meaningful gains in muscle strength and lean mass with creatine doses of 3-5 g per day, and the authors noted that creatine may partially offset the muscle and bone losses associated with estrogen decline. For a perimenopausal or postmenopausal woman already considering NMN for energy and metabolic health, adding creatine is a biologically coherent choice.

The Creatinine Elevation: What It Means and What It Doesn't

Why Your Lab Value Goes Up

Every gram of creatine you take is eventually converted to creatinine at a fixed rate. Creatinine is filtered freely at the glomerulus and not reabsorbed, so plasma creatinine rises when the load increases. Studies have documented creatinine rises of 0.08 to 0.26 mg/dL during creatine supplementation in healthy individuals with normal kidneys. The rise is usually stable within two to four weeks and reverses within two to four weeks of stopping.

For a woman whose baseline creatinine is 0.65 mg/dL, a 0.2 mg/dL rise to 0.85 mg/dL is still well within normal range and clinically irrelevant. For a woman whose baseline is already 0.95 mg/dL due to mild chronic kidney disease or dehydration, the same rise could push her to 1.15 mg/dL, which most labs would flag and which could incorrectly suggest worsening renal function.

Does NMN or NR Add to the Creatinine Problem?

No evidence suggests that NMN or NR raise creatinine independently. NMN and NR are metabolized to NAD+ and its downstream metabolites, primarily nicotinamide, N-methyl nicotinamide, and methyl-2-pyridone-5-carboxamide, all of which are renally excreted but are not creatinine. High-dose niacin (nicotinamide) supplementation has been studied for renal effects and does not appear to raise creatinine at doses comparable to those produced by NMN or NR conversion.

So the creatinine concern belongs entirely to the creatine half of this stack, not to NMN or NR.

Is There Any True Pharmacological Interaction?

Separate Pathways, No Competition

Creatine and NMN or NR operate in distinct biochemical compartments:

• Creatine is synthesized from arginine and glycine in the liver and kidneys, stored as phosphocreatine in muscle, and recycled through the creatine kinase system.
• NMN and NR enter NAD+ biosynthesis via the Preiss-Handler and salvage pathways, neither of which involves creatine kinase, the creatine transporter (SLC6A8), or any shared enzyme.

There is no published mechanistic evidence that NAD+ repletion alters creatine uptake or vice versa. One 2023 review in the Journal of the International Society of Sports Nutrition noted that NAD+-dependent enzymes like PARP-1 and sirtuins influence mitochondrial biogenesis and may theoretically support the same energy systems that creatine feeds during explosive exercise, but this is a downstream combination in effect, not a direct interaction.

Timing: Does It Matter?

No pharmacokinetic data suggests you need to separate creatine and NMN or NR by any specific time window. Creatine absorption peaks roughly 90 minutes after ingestion. NMN is rapidly absorbed and peaks in plasma within 2-3 minutes in mouse models, with human pharmacokinetic data suggesting similar rapid uptake. They do not share a transporter and do not compete for intestinal absorption.

A practical recommendation: take your NMN or NR in the morning (some evidence suggests morning timing aligns with circadian NAD+ biology) and your creatine whenever is convenient for your routine, often post-workout or with a meal.

Kidney Safety: Who Needs to Be Careful

Women at Higher Risk From Creatine

Before adding creatine to any stack that involves kidney-relevant lab monitoring, consider your individual risk profile. Women with any of the following should consult a clinician before starting creatine:

• Estimated GFR below 60 mL/min/1.73m2 (CKD Stage 3 or worse)
• History of kidney stones (creatine increases oxalate excretion in some individuals)
• Polycystic kidney disease
• Diabetes with microalbuminuria
• Use of NSAIDs, metformin, or ACE inhibitors, all of which have renal considerations

For women with PCOS who are already taking metformin, this is worth raising with your prescriber. Metformin's dose adjustments are tied to eGFR thresholds. A creatine-induced creatinine rise could theoretically trigger an unnecessary metformin dose reduction if your clinician does not know you are supplementing.

Monitoring Protocol

A reasonable monitoring approach for women starting both NMN/NR and creatine together:

1. Baseline labs before starting: serum creatinine, BUN, eGFR, and a urinalysis.
2. Repeat at 8-12 weeks after starting creatine at your maintenance dose.
3. Tell your lab or clinician you are taking creatine, so any creatinine elevation is interpreted in context.
4. If creatinine rises more than 0.3 mg/dL or eGFR drops more than 15 points, stop creatine and recheck in four weeks to see if values return to baseline.

Pregnancy, Lactation, and Contraception

This section is required reading if you are pregnant, trying to conceive, or breastfeeding.

NMN and NR in Pregnancy

Neither NMN nor NR has been studied in human pregnancies. Animal data shows that NAD+ precursors are critical to embryogenesis: a 2018 landmark study in the New England Journal of Medicine found that NAD+ deficiency during embryonic development caused congenital heart defects and miscarriage in mice, and identified HAAO and KYNU gene mutations in families with recurrent miscarriage and birth defects. This finding has generated interest in NMN supplementation during pregnancy, but no human RCT has tested NMN or NR supplementation in pregnant women for safety or efficacy. The FDA does not regulate these supplements for this indication. Given the absence of human safety data, both NMN and NR should be avoided during pregnancy unless prescribed and supervised by a maternal-fetal medicine specialist in a research context.

Lactation transfer data does not exist. NAD+ and its metabolites are present in breast milk naturally, but whether supplemental NMN or NR raises breast milk NAD+ levels to any meaningful or potentially harmful degree is unknown. Avoid during breastfeeding.

Creatine in Pregnancy and Lactation

Creatine has been studied in animal models of pregnancy with some interest as a neuroprotective agent for the fetus during hypoxic stress. However, no adequate human RCTs support creatine supplementation during human pregnancy, and current guidance does not recommend it outside of research settings. Creatine passes into breast milk, but the clinical significance for a breastfed infant is unknown. The standard recommendation is to avoid creatine supplementation during pregnancy and lactation unless a maternal-fetal medicine specialist determines otherwise.

Trying to Conceive

If you are actively trying to conceive, the evidence does not support stopping creatine immediately, as creatine itself does not appear to affect ovulation or hormonal status. NMN and NR, similarly, have no known effect on fertility in women, though the data is thin. The prudent approach is to stop both before a confirmed pregnancy.

Who This Stack Is Right For (and Who Should Think Twice)

Good Candidates

• Perimenopausal and postmenopausal women looking to support muscle mass, metabolic health, and cellular energy. This is the group with the most relevant trial data for both supplements individually.
• Women with PCOS who are not pregnant and who have been counseled on the creatinine-lab consideration, particularly if they are also on metformin.
• Active women over 40 who strength-train and want to address both creatine depletion and the age-related NAD+ decline simultaneously.
• Women with normal kidney function (eGFR above 60) who have had recent baseline labs.

Women Who Should Be Cautious or Avoid

• Pregnant or breastfeeding women: avoid both NMN/NR and high-dose creatine.
• Women with CKD Stage 3 or worse: creatine is not recommended without nephrologist clearance.
• Women on medications with narrow renal dosing windows (lithium, certain antifungals, renally cleared antibiotics): the creatinine elevation from creatine could confound dose adjustments.
• Women with a history of kidney stones: assess with a clinician first.

Dosing Guidance for Women

NMN Dosing

Most published human trials have used 250-500 mg per day of NMN. The Nature Aging 2023 trial used 900 mg per day without significant adverse effects. No dose has been established as optimal for women specifically. Starting at 250 mg per day in the morning and titrating up to 500 mg over four to eight weeks is a practical approach that aligns with trial protocols.

NR Dosing

NR has been studied at 250-1,000 mg per day. The Cell Metabolism 2018 pharmacokinetic study used 1,000 mg per day. A 300-500 mg per day starting dose is reasonable for most women.

Creatine Dosing for Women

Skip the traditional loading phase (20 g per day for five days) if you want to minimize the acute creatinine spike and any GI discomfort. A flat 3-5 g per day reaches muscle saturation in three to four weeks with a smoother lab profile. Women with body weight below 60 kg may do well at 3 g per day. Research in female athletes and postmenopausal women consistently shows benefits at 3-5 g per day without requiring a loading protocol.

What the Evidence Gap Looks Like

Women have been systematically underrepresented in sports supplement and longevity supplement research. As of mid-2025, no published RCT has enrolled women to test NMN or NR combined with creatine and measured outcomes relevant to female health: muscle mass, bone density, insulin sensitivity by menstrual phase, or hormonal status. The guidance in this article is built from:

• Sex-stratified data from creatine trials in women.
• Female-only NAD+ precursor trials (notably the 2021 postmenopausal NMN trial).
• Mechanistic reasoning from known biochemistry.
• Expert consensus in sports nutrition (ISSN position stands) and menopause medicine.

That is not nothing. But it means the specific combination in a 44-year-old perimenopausal woman with PCOS remains extrapolated territory, and you deserve to know that before you add both capsules to your morning routine.

Practical Takeaways: Your Monday-Morning Checklist

Before you start the combination:

1. Get baseline labs: creatinine, BUN, eGFR.
2. Tell your prescriber you are taking creatine (not NMN/NR, which does not affect creatinine) so future labs are interpreted correctly.
3. Choose your dose: start NMN at 250 mg in the morning; start creatine at 3-5 g with food.
4. No need to separate them by time.
5. Recheck creatinine and eGFR at 8-12 weeks.
6. If you are perimenopausal or postmenopausal, ask your clinician whether the ISSN's 2021 position stand on creatine in older adults supports adding it to your resistance-training program before you start.

If your creatinine rises more than 0.3 mg/dL and does not come down within four weeks of stopping creatine, that warrants a nephrology referral, not reassurance.